Boehringer Ingelheim: Christine Sakdalan and Mike Jablonski talk precision psychiatry

Power to the Patients

Apr 09 2025 | 00:40:32

00:00 / 00:40:32

Show Notes

In this episode of Power to the Patients, Boehringer Ingelheim leaders Christine Sakdalan and Mike Jablonski from discuss how precision psychiatry—using tools like biomarkers and neuroimaging—can personalize treatment for conditions like schizophrenia and depression. They highlight the importance of holistic care, digital therapeutics, and industry collaboration to address unmet needs and improve outcomes in mental health.

Other Episodes

Episode

October 11, 2023 • 00:26:22

Patient advocacy with Stephanie E. Saville, Foundation Manager for the Pediatric Retinal Research Foundation

As the dedicated Foundation Manager for the Pediatric Retinal Research Foundation (PRRF), Stephanie Saville offers a unique and enlightening perspective into the specialized area...

Episode 5

June 06, 2025 • 00:39:35

Backing Breakthroughs in Psychedelics

Dina Burkitbayeva, CEO of Freedom Biosciences, shares how she launched one of the first venture funds focused on mental health innovation. After co-founding PsyMed...

Episode 2

May 12, 2025 • 00:42:17

Spyros Papapetropoulos, CEO of Neuphoria

Spyros Papapetropoulos, a leading neurologist and neuroscientist, joins Power CEO, Brandon Li, to discuss his remarkable career and the transformative work at Neuphoria. Spyros...